Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix

Gynecologic Oncology

Volumn 107, Issue 1, 2007, Pages 45-51

  Longatto Filho, Adhemar ^a,b   Pinheiro, Céline ^a   Pereira, Sônia Maria Miranda ^b   Etlinger, Daniela ^b   Moreira, Marise A R ^c   Jubé, Luiz Fernando ^d   Queiroz, Geraldo Silva ^d   Baltazar, Fátima ^a   Schmitt, Fernando C ^e,f  

^a UNIVERSITY OF MINHO   (Portugal)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d Hospital Araujo Jorge   (Brazil)

^e UNIVERSITY OF PORTO   (Portugal)

^f University of Porto   (Portugal)

Author keywords

Cervical carcinoma; COX 2; D2 40; EGFR; HPV; Intraepithelial cervical lesions; Lymphangiogenesis

Indexed keywords

CYCLOOXYGENASE 2; D2 40 ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CLINICAL EVALUATION; CORRELATION FUNCTION; DENSITY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE; LYMPH VESSEL; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STATISTICAL SIGNIFICANCE; TUMOR CELL; UTERINE CERVIX; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLOOXYGENASE 2; EPITHELIUM; FEMALE; HUMANS; LYMPHANGIOGENESIS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; UTERINE CERVICAL NEOPLASMS;

EID: 34848820034     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.05.029     Document Type: Article

References (24)

1. Woodman C.B., Collins S.I., and Young L.S. The natural history of cervical HPV infection: unresolved issues. Nat. Rev., Cancer 7 (2007) 11-22
2. Ault K.A. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect. Dis. Obstet. Gynecol. 14 (2006) 40470
3. Kalof A.N., and Cooper K. Our approach to squamous intraepithelial lesions of the uterine cervix. J. Clin. Pathol. 60 (2007) 449-455
4. Van Trappen P.O., Steele D., Lowe D.G., et al. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J. Pathol. 201 (2003) 544-554
5. Van Trappen P.O., and Pepper M.S. Lymphangiogenesis in human gynaecological cancers. Angiogenesis 6 (2005) 1-9
6. Reis-Filho J.S., and Schmitt F.C. Lymphangiogenesis in tumours: what do we know?. Microsc. Res. Tech. 60 (2003) 171-180
7. von Rahden B.H., Brucher B.L., Langner C., et al. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine. Br. J. Surg. 93 (2006) 1424-1432
8. Zhang J., Ji J., Yuan F., et al. Cyclooxygenase-2 expression is associated with VEGF-C and lymph node metastases in gastric cancer patients. Biomed. Pharmacother. 59 Suppl. 2 (2005) S285-S288
9. Kyzas P.A., Stefanou D., and Agnantis N.J. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod. Pathol. 18 (2005) 153-160
10. Su J.L., Shih J.Y., Yen M.L., et al. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 64 (2004) 554-564
11. Timoshenko A.V., Chakraborty C., Wagner G.F., et al. COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br. J. Cancer 94 (2006) 1154-1163
12. Niu G., Wright K.L., Huang M., et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21 (2002) 2000-2008
13. Bjorndahl M.A., Cao R., Burton J.B., et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65 (2005) 9261-9268
14. Dumoff K.L., Chu C., Xu X., et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod. Pathol. 18 (2005) 97-104
15. Urabe A., Matsumoto T., Kimura M., et al. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology 49 (2006) 493-497
16. Tavassoli F.A., and Deville P. Tumours of the breast and female genital organs. World Health Organization Classification of Tumours (2003), IARC Press, WHO, Lyon
17. Baltazar F., Longatto-Filho A., Pinheiro C., Moreira M.A.R., Queiroz G.S., Oton G.J.B., et al. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expressions in different histological subtypes of cervix carcinomas. Int J Gynecol Pathol 26 (2007) 235-241
18. Schiffman M., and Kjaer S.K. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J. Natl. Cancer Inst. Monographs 31 (2003) 14-19
19. Bjorndahl M.A., Cao R., Burton J.B., et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65 (2005) 9261-9268
20. Smith-McCune K., Zhu Y.H., Hanahan D., et al. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57 (1997) 1294-1300
21. Urabe A., Matsumoto T., Kimura M., et al. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology 49 (2006) 493-497
22. Chargui R., Damak T., Khomsi F., et al. Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix. Am. J. Obstet. Gynecol. 194 (2006) 43-48
23. Yasuda S., Kojima A., Maeno Y., et al. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymph node metastasis. Kobe J. Med. Sci. 52 (2006) 9-15
24. Achen M.G., Mann G.B., and Stacker S.A. Targeting lymphangiogenesis to prevent tumour metastasis. Br. J. Cancer 94 (2006) 1355-1360